JUPITER, Fla., Nov. 19, 2012 /PRNewswire/ -- Dyadic International, Inc. (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical and industrial enzyme industries, announced today that it has been issued U.S. Patent No. 8,304,212 entitled "Methods and compositions for degradation of lignocellulosic material" by the United States Patent and Trademark Office ("USPTO").
The inventions embodied by this patent relate to methods and compositions for using enzyme mixtures to convert plant biomass into fermentable sugars for the production of useful products. The inventions also relate to novel combinations of enzymes including those that provide a synergistic release of sugars from plant biomass.
Dyadic's President and CEO, Mark Emalfarb, stated, "In developing and selling industrial enzymes, our customers and partners not only benefit from Dyadic's patented C1 platform technology but also from Dyadic's fungal strains and technologies based on the Trichoderma fungal organism. Dyadic uses these strains to produce specialty enzymes that can be used for a variety of applications in such fields as animal health and nutrition, biofuels and bio-based chemicals. As with our growing portfolio of patents covering the C1 technology, this patent will provide Dyadic, its customers and licensees with additional protection for our Trichoderma-based enzyme mixtures."
The patent also specifically describes methods of increasing the yield of fermentable sugars from fermentation of Distillers Dried Grains (DDGs) using enzyme mixtures comprising glucoamylase, beta-glucosidase and alpha-arabinofuranosidase. DDGs are obtained after the fermentation of the starch der
|SOURCE Dyadic International, Inc.|
Copyright©2012 PR Newswire.
All rights reserved